These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Author: Tarantino G, Saldalamacchia G, Conca P, Arena A.
    Journal: J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757.
    Abstract:
    Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.
    [Abstract] [Full Text] [Related] [New Search]